Page last updated: 2024-10-17

aminocaproic acid and Delayed Effects, Prenatal Exposure

aminocaproic acid has been researched along with Delayed Effects, Prenatal Exposure in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandrov, VA1
Bespalov, VG2
Petrov, AS2
Troyan, DN1
Aleksandrov, VA1
Troian, DN1

Other Studies

2 other studies available for aminocaproic acid and Delayed Effects, Prenatal Exposure

ArticleYear
Study of post-natal effect of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. III. Inhibitory action of indomethacin, voltaren, theophylline and epsilon-aminocaproic acid.
    Carcinogenesis, 1996, Volume: 17, Issue:9

    Topics: Aminocaproic Acid; Animals; Anticarcinogenic Agents; Brain Neoplasms; Carcinogens; Central Nervous S

1996
[The inhibiting effect of epsilon-aminocaproic acid on the incidence of induced tumors of the esophagus, nervous system and kidneys].
    Voprosy onkologii, 1992, Volume: 38, Issue:1

    Topics: Aminocaproic Acid; Animals; Anticarcinogenic Agents; Carcinogens; Chi-Square Distribution; Dimethyln

1992